Systematic Review Certainty of Evidence and Procedural Durability of Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: An Umbrella Review of Meta-Analyses.
Arthur Cordeiro Simão, Marcos Benito Gonçalves de Oliveira, Antônio da Silva Menezes Junior
{"title":"Systematic Review Certainty of Evidence and Procedural Durability of Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: An Umbrella Review of Meta-Analyses.","authors":"Arthur Cordeiro Simão, Marcos Benito Gonçalves de Oliveira, Antônio da Silva Menezes Junior","doi":"10.1159/000552974","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This umbrella review aimed to evaluate the certainty and consistency of the available evidence rather than to provide a new procedural comparison. We synthesized systematic reviews comparing surgical septal myectomy (SM) versus alcohol septal ablation (ASA) for symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to critically assess the certainty of findings.</p><p><strong>Methods: </strong>An umbrella review of meta-analyses was conducted following Cochrane and PRISMA guidelines. A systematic search of four databases was performed. Methodological quality, risk of bias, and study overlap were assessed. Quantitative synthesis was performed using a random-effects model, and the certainty of evidence was classified using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.</p><p><strong>Results: </strong>Six meta-analyses comprising 31 unique primary studies and 12,860 patients were included, demonstrating very high study overlap. ASA was associated with a significantly higher risk of reoperation compared to SM, supported by high-certainty evidence. Conversely, for all other outcomes, including mortality and permanent pacemaker implantation, the certainty of evidence was consistently classified as very low due to inconsistency and imprecision.</p><p><strong>Conclusion: </strong>High-certainty evidence supports SM as the more durable intervention for oHCM, demonstrated by a reduced need for reoperations. Notably, the evidence for mortality outcomes is of very low certainty, precluding definitive conclusions regarding clinical equivalence or technique superiority. This review identifies current knowledge gaps regarding survival benefits to inform clinical practice and future research.</p>","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"1-10"},"PeriodicalIF":1.9000,"publicationDate":"2026-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000552974","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: This umbrella review aimed to evaluate the certainty and consistency of the available evidence rather than to provide a new procedural comparison. We synthesized systematic reviews comparing surgical septal myectomy (SM) versus alcohol septal ablation (ASA) for symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to critically assess the certainty of findings.
Methods: An umbrella review of meta-analyses was conducted following Cochrane and PRISMA guidelines. A systematic search of four databases was performed. Methodological quality, risk of bias, and study overlap were assessed. Quantitative synthesis was performed using a random-effects model, and the certainty of evidence was classified using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.
Results: Six meta-analyses comprising 31 unique primary studies and 12,860 patients were included, demonstrating very high study overlap. ASA was associated with a significantly higher risk of reoperation compared to SM, supported by high-certainty evidence. Conversely, for all other outcomes, including mortality and permanent pacemaker implantation, the certainty of evidence was consistently classified as very low due to inconsistency and imprecision.
Conclusion: High-certainty evidence supports SM as the more durable intervention for oHCM, demonstrated by a reduced need for reoperations. Notably, the evidence for mortality outcomes is of very low certainty, precluding definitive conclusions regarding clinical equivalence or technique superiority. This review identifies current knowledge gaps regarding survival benefits to inform clinical practice and future research.
期刊介绍:
''Cardiology'' features first reports on original clinical, preclinical and fundamental research as well as ''Novel Insights from Clinical Experience'' and topical comprehensive reviews in selected areas of cardiovascular disease. ''Editorial Comments'' provide a critical but positive evaluation of a recent article. Papers not only describe but offer critical appraisals of new developments in non-invasive and invasive diagnostic methods and in pharmacologic, nutritional and mechanical/surgical therapies. Readers are thus kept informed of current strategies in the prevention, recognition and treatment of heart disease. Special sections in a variety of subspecialty areas reinforce the journal''s value as a complete record of recent progress for all cardiologists, internists, cardiac surgeons, clinical physiologists, pharmacologists and professionals in other areas of medicine interested in current activity in cardiovascular diseases.